Results 131 to 140 of about 24,398 (299)

Kegigihan dan komitmen luar biasa, Nabil Aiman raih Anugerah Emas Universiti [PDF]

open access: yes
GAMBANG, 8 November 2025 – Kegigihan dan komitmen luar biasa dalam menimba ilmu akhirnya membuahkan kejayaan apabila Muhammad Nabil Aiman Abu Bakar, graduan Diploma Keselamatan dan Kesihatan Pekerjaan dari Universiti Malaysia Pahang Al-Sultan Abdullah ...
Noraini, Yusoff
core  

Efficacy, safety and cost‐effectiveness of CAR‐T therapy

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
CAR T‐cells demonstrate high efficacy in blood cancers, including ALL, MM and DLBCL. Innovations target solid tumours despite challenges such as antigen escape. Combination therapies enhance the delivery and infiltration of CAR T cells. Toxicity, cost and resistance remain major barriers to clinical use.
Emina Karahmet Sher   +7 more
wiley   +1 more source

Do drugs approved via expedited approval pathways have therapeutic advantages? A systematic review and meta‐analysis

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Regulators use expedited approval pathways to speed market approval and patient access to promising new drugs. However, there is uncertainty about whether these pathways are successful in approving drugs with significant therapeutic advantages. This systematic review aims to examine the safety, effectiveness and cost‐effectiveness of drugs approved via
Ashleigh Hooimeyer   +4 more
wiley   +1 more source

Comparative efficacy of GLP‐1 RA, tirzepatide and SGLT‐2 inhibitors in metabolic liver disease: A network meta‐analysis

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aim Metabolic liver disease, including nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis, is a major cause of chronic liver dysfunction worldwide, creating an urgent need for effective treatments. This systematic literature review (SLR) and network meta‐analysis (NMA) systematically reviews and compares the efficacy and safety ...
Andrej Belančić   +8 more
wiley   +1 more source

EMAS [PDF]

open access: yesTempo, 1978
openaire   +1 more source

Meie ema

open access: yes, 2023
https://www.ester.ee/record=b1302459 ...
openaire   +1 more source

Increasing the reporting of adverse drug reaction‐related hospitalizations using an ICD‐10‐based identification workflow: A multicentre study from Switzerland

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Background Reporting adverse drug reactions (ADRs) is essential for drug safety. In Switzerland, healthcare professionals are legally required to report serious and unlabelled ADRs, yet under‐reporting remains widespread. We tested a novel method to increase reporting of ADR‐related hospitalizations.
Georgia Anita Weber   +7 more
wiley   +1 more source

TA : Pemodelan Arima Untuk Peramalan Harga Emas [PDF]

open access: yes, 2013
Emas merupakan logam mulia yang sering dijadikan sebagai alat tukar dalam perdagangan maupun sebagai standar keuangan berbagai negara (Joesoef: 2008). Nilai emas yang tidak pernah mengalami penyusutan membuat pelaku bisnis atau masyarakat sering memilih ...
Santoso, Denny Achmad
core  

Decoding RNA regulation: Challenges and opportunities for RNA‐based therapies in Europe

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Abstract RNA‐based medicinal products represent a promising frontier in personalised medicine, offering sequence‐specific disease targeting at various molecular levels, yet their clinical translation in the European Union (EU) may be hindered by regulatory uncertainty around definitions and evidence requirements; this study therefore aims to identify ...
Olivia C. Lewis   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy